B L Adler1, A B Crew1, D T Woodley1. Show Affiliations » 1. Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Abstract
Entities: Chemical Disease
Mesh： See more » Antibodies, Monoclonal, Murine-Derived/therapeutic useFemaleFilgrastim/administration & dosageFilgrastim/therapeutic useHematologic Agents/therapeutic useHumansInfusions, IntravenousInjections, SubcutaneousMiddle AgedNeutropenia/chemically inducedNeutropenia/drug therapyPemphigoid, Bullous/complicationsPemphigoid, Bullous/drug therapyPemphigoid, Bullous/pathologyRituximab/administration & dosageRituximab/adverse effectsRituximab/therapeutic useTreatment Outcome
Substances： See more » Antibodies, Monoclonal, Murine-DerivedHematologic AgentsRituximabFilgrastim
Year: 2018 PMID： 30151931 DOI： 10.1111/ced.13726
Source DB: PubMed Journal: Clin Exp Dermatol ISSN： 0307-6938 Impact factor: 3.470